Trademark Overview
On Thursday, May 29, 2025, a trademark application was filed for ISEMBYLD with the United States Patent and Trademark Office. The USPTO has given the ISEMBYLD trademark a serial number of 99208503. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, May 29, 2025. This trademark is owned by Scholar Rock, Inc.. The ISEMBYLD trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the treatment of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the treatment of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
patient and caregiver support services and medical information relating to spinal muscular atrophy (SMA), apitegromab preparations, case management, financial assistance, copay support, reimbursement support, drug access, patient and caregiver education, and support for infusions and infusion logistics
research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products
